Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 6

BMD at the distal third of radius.

	Baseline (% of YAM)	1 year (% of YAM)	% change
Denosumab	56.7 ± 7.2	58 ± 7.9	2.6 ± 4.4%
Control	54.7 ± 11	52.3 ± 10.1	−4.5 ± 7.7%
value			<0.001

BMD: bone mineral density; YAM: young adult mean.